Cidara Therapeutics Inc (CDTX)
13.74
+0.06
(+0.44%)
USD |
NASDAQ |
May 07, 13:48
Cidara Therapeutics Cash from Investing (TTM): -0.505M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.505M |
September 30, 2023 | -0.336M |
June 30, 2023 | -0.219M |
March 31, 2023 | -0.128M |
December 31, 2022 | -0.118M |
September 30, 2022 | -0.109M |
June 30, 2022 | -0.112M |
March 31, 2022 | -0.113M |
December 31, 2021 | -0.041M |
September 30, 2021 | -0.041M |
June 30, 2021 | -0.083M |
March 31, 2021 | -0.162M |
December 31, 2020 | -0.186M |
September 30, 2020 | -0.186M |
June 30, 2020 | -0.132M |
March 31, 2020 | -0.062M |
December 31, 2019 | -0.035M |
September 30, 2019 | 4.425M |
June 30, 2019 | 14.11M |
Date | Value |
---|---|
March 31, 2019 | 13.84M |
December 31, 2018 | 14.30M |
September 30, 2018 | 5.058M |
June 30, 2018 | -14.50M |
March 31, 2018 | -6.362M |
December 31, 2017 | 4.471M |
September 30, 2017 | 44.64M |
June 30, 2017 | 57.61M |
March 31, 2017 | 36.78M |
December 31, 2016 | 25.48M |
September 30, 2016 | -5.346M |
June 30, 2016 | -58.93M |
March 31, 2016 | -46.07M |
December 31, 2015 | -46.09M |
September 30, 2015 | -50.79M |
June 30, 2015 | -0.47M |
March 31, 2015 | -1.021M |
December 31, 2014 | -0.991M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.505M
Minimum
Dec 2023
14.11M
Maximum
Jun 2019
0.8405M
Average
-0.113M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Johnson & Johnson | -2.901B |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |